Clinical trial
Removal of Dolutegravir by Hemodialysis in HIV-infected Patients With End-stage Renal Disease
NCT02487706 is registered in ClinicalTrials.gov with Fundación FLS de Lucha Contra el Sida, las Enfermedades Infecciosas y la Promoción de la Salud y la Ciencia as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Removal of Dolutegravir by Hemodialysis in HIV-infected Patients With End-stage Renal Disease
- Lead sponsor
- Fundación FLS de Lucha Contra el Sida, las Enfermedades Infecciosas y la Promoción de la Salud y la Ciencia
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- June 30, 2015
- Completion date
- July 31, 2015
- Enrollment
- 5 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
hiv